Cardinal Health Inc. (CAH) Financial Statements (2026 and earlier)

Company Profile

Business Address 7000 CARDINAL PLACE
DUBLIN, OH 43017
State of Incorp. OH
Fiscal Year End June 30
Industry (SIC) 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

3/31/2026
MRQ
12/31/2025
MRQ
6/30/2025
6/30/2024
6/30/2023
6/30/2022
6/30/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2,7773,8745,1334,0434,7173,407
Cash and cash equivalent2,7773,8745,1334,0434,7173,407
Receivables13,66213,24212,08411,34410,5619,103
Inventory, net of allowances, customer advances and progress billings20,11616,83114,95715,94015,63614,594
Inventory20,11616,83114,95715,94015,63614,594
Other current assets2,6752,4142,6632,3622,0212,843
Other undisclosed current assets  1247144 1,101
Total current assets:39,23036,37334,88433,83332,93531,048
Noncurrent Assets
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization2,8772,8582,5292,4622,3612,360
Intangible asset, including goodwill, after accumulated amortization13,97812,1776,4506,0817,62910,094
Goodwill11,6099,6914,7254,6095,8557,989
Intangible asset, excluding goodwill, after accumulated amortization2,3692,4861,7251,4721,7742,105
Other noncurrent assets1,9981,7141,2581,041953951
Total noncurrent assets:18,85316,74910,2379,58410,94313,405
TOTAL ASSETS:58,08353,12245,12143,41743,87844,453
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities42,63438,34735,20632,87229,97026,657
Accounts payable38,99634,71331,75929,81327,12823,700
Accrued liabilities3,6383,6343,4473,0592,8422,957
Debt680550434792580871
Other undisclosed current liabilities    42 96
Total current liabilities:43,31438,89735,64033,70630,55027,624
Noncurrent Liabilities
Long-term debt and lease obligation, including:8,3477,9774,6583,9094,7355,365
Finance lease, liability  15775594945
Other undisclosed long-term debt and lease obligation8,3477,8204,5833,8504,2985,320
Liabilities, other than long-term debt  654400375  
Operating lease, liability  654400375388 
Other undisclosed noncurrent liabilities9,1228,2287,6358,2788,9119,670
Total noncurrent liabilities:17,46916,85912,69312,56214,03415,035
Total liabilities:60,78355,75648,33346,26844,58442,659
Equity
Equity, attributable to parent(2,884)(2,781)(3,213)(2,852)(709)1,791
Common stock2,8472,9562,9172,7472,8132,806
Treasury stock, value(7,033)(6,365)(5,677)(4,914)(3,128)(2,186)
Accumulated other comprehensive loss(153)(155)(167)(151)(114)(34)
Retained earnings (accumulated deficit)1,455783(286)(534)(280)1,205
Equity, attributable to noncontrolling interest1841471133
Total equity:(2,700)(2,634)(3,212)(2,851)(706)1,794
TOTAL LIABILITIES AND EQUITY:58,08353,12245,12143,41743,87844,453

Income Statement (P&L) ($ in millions)

3/31/2026
TTM
12/31/2025
TTM
6/30/2025
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Revenues244,673222,578226,827205,012181,364162,467
Cost of revenue
(Cost of Product and Service Sold)
(235,632)(214,410)(219,413)(198,123)(174,819)(155,689)
Gross profit:9,0418,1687,4146,8896,5456,778
Operating expenses(5,728)(5,285)(5,253)(4,627)(4,767)(5,776)
Other undisclosed operating loss(780)(608)(918)(1,535)(2,374)(530)
Operating income (loss):2,5332,2751,243727(596)472
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
604194(16)47
Interest and debt expense  (51)(93)(159)(194)
Other undisclosed loss from continuing operations before equity method investments, income taxes      (2)
Income (loss) from continuing operations before equity method investments, income taxes:2,5932,3161,201638(771)323
Other undisclosed income (loss) from continuing operations before income taxes(316)(215)  2 
Income (loss) from continuing operations before income taxes:2,2772,1011,201638(769)323
Income tax expense (benefit)(601)(532)(348)(376)(163)289
Income (loss) from continuing operations:1,6761,569853262(932)612
Income (loss) before gain (loss) on sale of properties:✕✕✕✕✕(932)612
Net income (loss):1,6761,569853262(932)612
Net income (loss) attributable to noncontrolling interest(14)(8)(1)(1)(1)(1)
Net income (loss) available to common stockholders, diluted:1,6621,561852261(933)611

Comprehensive Income ($ in millions)

3/31/2026
TTM
12/31/2025
TTM
6/30/2025
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Net income (loss):1,6761,569853262(932)612
Other comprehensive income (loss)2712(16)(37)(80)70
Comprehensive income (loss):1,7031,581837225(1,012)682
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(14)(8)(1)(1)(1)(1)
Comprehensive income (loss), net of tax, attributable to parent:1,6891,573836224(1,013)681

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: